PACTT is proud to announce that Genknowme, a spin-off of the University of Lausanne founded by Semira Gonseth and Sébastien Nusslé, won the VentureKick competition and received a grant of CHF 150’000.
Protéger et commercialiser son invention s’apparente parfois à un casse-tête pour les chercheurs. Le magazine In Vivo du CHUV décrypte le soutien apporté par les bureaux de transfert de technologies, et notamment par le PACTT.
Due to the coming holiday season, please note that our office will be closed from December 24, 2019 until January 3, 2020.
We will reopen on Monday, January 6, 2020.
PACTT team wishes you a wonderful holiday season!
Starting on October 14, 2019, a 4 week online course is jointly organized by the School of Life Sciences, EPFL, and the College of Sciences, San Diego State University :
“FROM THE LAB BENCH TO THE BEDSIDE – A FANTASTIC VOYAGE OF DRUG/DEVICE DEVELOPMENT”
Experienced instructors from Europe and the US will introduce you to the fundamentals of drug/device development, and the requirements for regulatory and quality compliance. You will have exposure to the requirements in Europe and the US in terms of the approach, the attitude to risk-taking, and the cultural divide.
Advances in biotechnology, medical technology, and information technology give new hope for treating diseases never imagined before. To bring these advances from the laboratory bench to the patient bedside requires training and experience that are not available in academia. This course is intended to fill that gap. It is a four-week interactive course, involving intensive self-study and team-work. The course will bring you close to your future workplace.
Students who successfully complete this course will be able to:
• Describe the major steps of the drug and device development process from bench to bed-side.
• Compare and contrast US and European Union regulatory and quality requirements.
• Discuss the basics of a Quality Management System.
• Develop a Product Profile for a drug/device product or therapy.
• Draft the basic components of a Development Plan for a Phase 1 clinical trial, including a Preclinical Plan, a Clinical Trial Protocol, and CMC (Chemistry, Manufacturing and Controls) Plan.
• Work with other life science professionals on a team.
• Feel more confident about job seeking and job interviews.
Register at
https://www.epfl.ch/schools/sv/school-of-life-sciences/innovation/catalyze4life/educate-to-innovate/
• The course is open to all members of Swiss Academic Institutions. Minimum of a Bachelor degree, in a relevant field, is required to participate
• Members of early start ups, strictly linked to a Swiss University, may be eligible; please contact the organizer
• Price for Non EPFL members is 400 CHF, Price for EPFL members is 200 CHF, Payment online shall be possible from September
• There are limited places; 1st come, 1st served
• Deadline is September 30
Contact
Program Director : Kostas Kaloulis
Email : catalyze4life@epfl.ch
In its strategic objectives, the Federal Council gives Innosuisse the mandate to support more innovation projects in non-technological areas, given their major interest for the economy. Innosuisse invites you to submit applications for this type of innovation project and to provide your comments on the new information about the various fields in the online application form. Projects submitted before 16 October 2019 can already start this year.
Read more (text in French and German only)